Cerevel Therapeutics Holdings, Inc.
CEREDelisted Aug 1, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001805387
Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.
Q4 2023 vs. Q3 2023
How the institutions holding Cerevel Therapeutics Holdings, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 119 | 195 | +76 |
| Shares | 140.8M | 155.8M | +15.1M (+10.7%) |
| Value | $3.07B | $6.61B | +$3.53B (+115.0%) |
New holders (91)
Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (15)
Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 1,824,387 | $39.8M |
| Logos Global Management LP | 700,000 | $15.3M |
| Finepoint Capital LP | 563,345 | $12.3M |
| TD Asset Management Inc | 372,146 | $8.12M |
| Great Point Partners LLC | 215,000 | $4.69M |
| Bank of Montreal | 96,014 | $2.18M |
| Tudor Investment Corp Et Al | 79,450 | $1.73M |
| Edgestream Partners, L.P. | 65,125 | $1.42M |
| DAFNA Capital Management LLC | 62,200 | $1.36M |
| Graham Capital Management, L.P. | 41,850 | $913.6K |
| Trexquant Investment LP | 14,397 | $314.3K |
| XTX Topco Ltd | 13,739 | $299.9K |
| Dark Forest Capital Management LP | 12,247 | $267.4K |
| Polar Capital Holdings Plc | 10,762 | $234.9K |
| Virtus ETF Advisers LLC | 2,895 | $63.2K |